Share Name Share Symbol Market Type Share ISIN Share Description
Horizon Discovery Group Plc LSE:HZD London Ordinary Share GB00BK8FL363 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 116.00 63,392 16:35:04
Bid Price Offer Price High Price Low Price Open Price
119.50 121.00 122.00 116.00 116.50
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 58.73 -40.65 -23.90 175
Last Trade Time Trade Type Trade Size Trade Price Currency
17:04:19 O 1,600 120.64 GBX

Horizon Discovery (HZD) Latest News

More Horizon Discovery News
Horizon Discovery Takeover Rumours

Horizon Discovery (HZD) Discussions and Chat

Horizon Discovery Forums and Chat

Date Time Title Posts
07/4/202006:43Horizon Discovery Ltd - Genomic translation 1,305
04/10/201812:17Horizon Discovery (HZD) One to Watch -
23/7/201415:43Alan Green says to BUY and HOLD in Horizon-

Add a New Thread

Horizon Discovery (HZD) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-04-08 16:04:39120.641,6001,930.24O
2020-04-08 15:35:04116.007,8169,066.56UT
2020-04-08 15:27:42121.002631.46AT
2020-04-08 15:27:42121.00216261.36AT
2020-04-08 15:27:42121.002631.46AT
View all Horizon Discovery trades in real-time

Horizon Discovery (HZD) Top Chat Posts

Horizon Discovery Daily Update: Horizon Discovery Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker HZD. The last closing price for Horizon Discovery was 116p.
Horizon Discovery Group Plc has a 4 week average price of 96p and a 12 week average price of 96p.
The 1 year high share price is 198p while the 1 year low share price is currently 96p.
There are currently 150,692,631 shares in issue and the average daily traded volume is 607,933 shares. The market capitalisation of Horizon Discovery Group Plc is £174,803,451.96.
bouleversee: So that shouldn't reflect on HZD one way or another. Just a tidy up operation between the other 2 companies. I wonder why HZD's share price has shot up today but I haven't checked to see whether the index has also done so. What do you think about their prospects going forward? I'm losing rather a lot on my holding and wondering whether to use the spare cash I have in my ISA to top up, or whether Next, RDSB, SMT, or Photo-Me would be a better bet. or whether none of them is worth topping up. Am losing on all but SMT and the rest of that ISA is a car crash and I wouldn't think of adding. HZD has the (very relevant to me)AIM IHT exemption at present, but for how much longer? And I wonder how long ISAs will survive. The chancellor is going to need to extract as much tax as possible.
jurgenklopp: kestlemill, the simple answer is that Americans value such stocks at far higher values than Brits. With an American listing you can see ValueAct engineering some kind of profitable get out like they did with Merlin Entertainment. Plus you have Cathie Wood from ARKinvest really rating the gene editing sub sector as one of her five categories for growth and, in one of the interviews on youtube, she stated that basically, if people understood how gene editing would affect our futures, the three largest US listed shares in the category would be worth nearer $200 billion rather than the $5 billion they are jointly worth now. Normally one can put these statements down as the rantings of a lunatic. However, over the last couple of years she has become rather well known as the person who said that people were valuing Tesla as a motor manufacturer when it should be treated as a high tech stock and, subsequently, set a price target of $4000 on the share. Therefore her opinions in the last week or so have become rather valued and I suspect many investors will start looking at the other sectors she has championed. ValueAct bought their first hefty chunk of HZD at around 214p where they must have seen some value at the time. They are pretty smart cookies too so you can easily see plenty of momentum behind the share price over the next few weeks or months. As a bonus no more involvement from Woodford cannot do any harm either !!
bouleversee: "Horizon has now exercised its option and Rutgers has granted it an exclusive license to Rutgers' proprietary Base Editing technology. The license includes the right for Horizon to sublicense the technology to entities seeking to use it for therapeutic development. Financial terms are confidential and have not been disclosed." Despite Terry Pizzie's statement that this should be transformative for HZD as it is claimed to be better/safer than Crispr/cas9 (see notes to Editors), the share price has dropped a fair bit rather than risen, as I had expected, however.
kestelmill: I've heard Centauri therapeutics is closing down, with the implication that Avvinity will be going on ice. I'm not sure if this would have a positive or negative impact on the share price. I would have thought positive but then it has lost 9% today? Any thoughts?
carpingtris: We getting results/update Monday?... does recent share price suggest anything? Worst performance in my pot by a long way! Luckily my bigger pots are fairing better.
jurgenklopp: I think Woodie still has a stash left - quite frankly if he sold now it would be a boost to the share price. There has still been no RNS as to where a large proportion of his recent sales have ended up - only that ValueAct had a top up but this does not account for all Woodford sales. The thing is that you can easily see a merger with the likes of Celyad or Abcam coming back or Softbank adding the company to the healthcare part of their vast fund. It ought to be an exciting ride.
jurgenklopp: amazing what freedom from Woodford does for the share price !!! ;o)
jurgenklopp: Yes indeed bouleversee. Woodford has been selling his most liquid stocks over the last day or two and the HZD price is getting clobbered just in anticipation of his holding being offered soon. For a day trader I would suggest there is little scope to get the timing exactly right as to where the turning point will be. However I take the view that firstly ValueAct considered HZD worth an initial large investment at 214p (if I recall correctly), secondly we are at the levels where Abcam tried a bid offering a premium (pitched at 180p) a couple of years ago, and thirdly, for any would be bidder (Abcam, Softbank or anyone else) we have a desperate seller holding 12% of the Company - a superb base from which to plan a takeover. I am not going to get the timing exactly right but these are currently outstanding value in my opinion.
jurgenklopp: Good morning chaps. ValueAct originally bought their first tranche at around 215p if I recall correctly. They have been adding since. Abcam tried a cheeky offer last year around the 180p mark. Woodford has been offloading (mainly to ValueAct) - a very good thing in my opinion. The purchase of Dharmacon is perceived to be a very astute deal. The update after the recent full year results looks very promising. If HZD was listed in America I suspect it would be valued at a far higher price than the current market cap. Either the performance of the Company (as it turns profitable) or the comparative low rating compared to US peers (thereby attracting a bidder) will transform the share price. I am confident of seeing a move up to previous highs (circa 250-260p) this year just on prospects alone. Any bid will see this north of 300p.
jurgenklopp: Some solid momentum behind the share price now !! The lack of an RNS regarding who ended up with the tranche sold by Invesco last week suggests a new substantial holder still below the declarable threshold. Combined with the strength of the share price suggests we could be in for an exciting ride. I still think this would be a perfect fit for the healthcare division of Softbank's huge investment vehicle.
Horizon Discovery share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Horizon Di..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200409 01:10:47